Pharmacogenetics of Risperidone: A Systematic Review of the Clinical Effects of CYP2D6 Polymorphisms

The AmpliChip® CYP450 Test and Response to Treatment in Schizophrenia and Obsessive Compulsive Disorder: A Pilot Study and Focus on Cases with Abnormal CYP2D6 Drug Metabolism

(2012) Daniel J. Müller et al.   Genetic Testing and Molecular Biomarkers

Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia

(2011) Maria J. Arranz et al.   CNS DRUGS

A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation

(2011) Shinichiro Ochi et al.   GENERAL HOSPITAL PSYCHIATRY

The Pharmacokinetics of Paliperidone Versus Risperidone

(2011) Jose de Leon et al.   PSYCHOSOMATICS

CYP2D6 Polymorphisms as Predictors of Outcome in Breast Cancer Patients Treated with Tamoxifen: Expanded Polymorphism Coverage Improves Risk Stratification

(2010) W. Schroth et al.   CLINICAL CANCER RESEARCH

The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone

(2010) Nikolina Jovanović et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effects of CYP2D6 Genotype on the Pharmacokinetics, Pharmacodynamics, and Safety of Risperidone in Healthy Volunteers

(2010) Jesús Novalbos et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia

(2010) Diego Novick et al.   PSYCHIATRY RESEARCH

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance

(2009) Shu-Feng Zhou   CLINICAL PHARMACOKINETICS

Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions

(2009) C T Correia et al.   PHARMACOGENOMICS JOURNAL